111 related articles for article (PubMed ID: 20418673)
1. Glioma diagnosis: immunohistochemistry and beyond.
Dunbar E; Yachnis AT
Adv Anat Pathol; 2010 May; 17(3):187-201. PubMed ID: 20418673
[TBL] [Abstract][Full Text] [Related]
2. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
3. Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors.
Kim SH; Kim H; Kim TS
Acta Neuropathol; 2005 Jul; 110(1):27-38. PubMed ID: 15920661
[TBL] [Abstract][Full Text] [Related]
4. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostics of gliomas: the clinical perspective.
Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.
Yip S; Iafrate AJ; Louis DN
J Neuropathol Exp Neurol; 2008 Jan; 67(1):1-15. PubMed ID: 18091559
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
8. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
10. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.
Schiff D; Brown PD; Giannini C
Neurology; 2007 Sep; 69(13):1366-73. PubMed ID: 17893297
[TBL] [Abstract][Full Text] [Related]
11. Pathology--trends and pitfalls in histologic diagnosis, immunopathology, and applications of oncogene research.
Burger PC; Fuller GN
Neurol Clin; 1991 May; 9(2):249-71. PubMed ID: 1682793
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokeratins in gliomas.
Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
[TBL] [Abstract][Full Text] [Related]
14. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
15. Global histone modification patterns as prognostic markers to classify glioma patients.
Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174
[TBL] [Abstract][Full Text] [Related]
16. An introduction to molecular analysis and characterization of gliomas.
Ausman JI
Surg Neurol; 2005 Oct; 64(4):285. PubMed ID: 16181992
[No Abstract] [Full Text] [Related]
17. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
19. Proteomics-based analysis of a pair of glioma cell lines with different tumor forming characteristics.
Zhou L; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Neurosci Lett; 2006 Jun; 401(1-2):59-64. PubMed ID: 16567038
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients.
McDonald KL; O'Sullivan MG; Parkinson JF; Shaw JM; Payne CA; Brewer JM; Young L; Reader DJ; Wheeler HT; Cook RJ; Biggs MT; Little NS; Teo C; Stone G; Robinson BG
J Neuropathol Exp Neurol; 2007 May; 66(5):405-17. PubMed ID: 17483698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
